Case 1 was in a 60-year-old mason who had a microfilaria count of 7 in a 60-µL night blood smear (NBS) in April 2025. The microfilaria was morphologically compatible with genus Dirofilaria. The patient was receiving treatment for diabetes mellitus and hypertension and had longstanding bilateral lower-limb swelling with no identifiable cause and a few palpable inguinal lymph nodes. Other physical examination results were unremarkable. Abdominal ultrasonography and ophthalmology screening results were unremarkable. After obtaining 5 mL of venous blood, we administered diethylcarbamazine (6 mg/kg/d for 12 d) and albendazole (400 mg). His microfilaremia was cleared at 5 weeks posttreatment.

Case 2 was in a 14-year-old boy who had a microfilaria count of 3/60 µL NBS in June 2025. The microfilaria was morphologically compatible with genus Dirofilaria. The patient had an occasional dry cough without diurnal variation. Hematology revealed eosinophilia of 568/μL (10.5%). Chest and abdominal imaging and echocardiography were unremarkable. He received doxycycline (100 mg 2×/d for 5 d) and albendazole (400 mg 2×/d for 5 d). Persistence of microfilaremia (1/60µL) at 1 month posttreatment necessitated a repeat course of treatment. His microfilaremia was cleared at 3 months posttreatment.

Figure 2

Figure 2. Microfilaria detected in Giemsa-stained thick blood smears from case-patients 1 (A) and 2 (B) in study of Dirofilaria infection and asymptomatic microfilaremia, Sri Lanka, 2025. Red arrows indicate...

Giemsa-stained NBSs from both case-patients at 1,000× magnification revealed microfilaria with morphology compatible with D. repens and D. asiatica worms (2). (Table; Figure 2). We performed molecular speciation to establish species identity. We extracted genomic DNA from venous blood of both patients using the QIAGEN Tissue Kit (QIAGEN, https://www.qiagen.com). We amplified mitochondrial cytochrome c oxidase subunit I (COI) gene using the primer pair COIfilF/COIfilR, designed from conserved nematode regions (9). We sequenced purified amplicons (QIAquick PCR Purification Kit; QIAGEN) bidirectionally by Sanger sequencing (SeqStudio Genetic Analyzer; Thermo Fisher Scientific, https://www.thermofisher.com) and deposited the resulting sequences in GenBank (accession nos. PZ359659 [AFC615] and PZ359660 [AFC621]). We edited chromatograms manually in BioEdit version 7.2.5 (https://www.updatestar.com) and queried against the National Center for Biotechnology Information nucleotide database using BLASTn (https://blast.ncbi.nlm.nih.gov/Blast.cgi) for homology assessment. We performed multiple sequence alignment using ClustalW in BioEdit. Both isolates were consistently identified as Dirofilaria asiatica; BLAST results showed near-complete query coverage (≈100%) and high percentage identity (>99%) to reference D. asiatica sequences, confirming species-level identification.

Figure 3

Figure 3. Maximum-likelihood phylogenetic tree generated in study of Dirofilaria asiatica infection and asymptomatic microfilaremia, Sri Lanka, 2025. Tree includes partial mitochondrial cox1 gene sequences from 2 ...

We constructed a maximum-likelihood phylogenetic tree in MEGA version 11 (10), using the best-fit substitution model selected by Bayesian Information Criterion (Figure 3). We assessed branch support using 1,000 bootstrap replicates and genetic distances estimated under the Kimura 2-parameter model. The resulting tree resolved 6 well-defined major clades, corresponding to D. asiatica, D. repens, D. immitis, D. ursi, Onchocerca sp., and Onchocercidae sp.; the deepest nodes separating the clades were supported at 10%–23%. Both study isolates, AFC615 and AFC621, clustered firmly within the D. asiatica clade alongside reference sequences also obtained from GenBank (accession nos. PV523839, PV523835, PV523843, and PV523842). Isolate AFC615 grouped closely with PV523839 and PV523835; bootstrap support was 99% at the terminal node and 97% and 91% at the supporting internal nodes. Isolate AFC621 formed a pair with reference sequence PV523842; the pair nested within the broader D. asiatica clade at 43% support. The clustering we observed was fully consistent with the BLASTn results, confirming both isolates as genuine D. asiatica.

Overall, the phylogenetic tree demonstrated clear separation of the 6 major clades (D. asiatica, D. repens, D. immitis, D. ursi, Onchocerca sp., and Onchocercidae sp.), with both study isolates aligning unambiguously within the D. asiatica lineage. The range of bootstrap support observed within this clade (22%–99%) reflects a degree of intraspecific genetic variation among D. asiatica sequences from different geographic sources, while clearly resolving both Sri Lanka isolates as D. asiatica (Figure 3).

Human Dirofilaria infections has been reported in Sri Lanka over many decades (6), although not specifically microfilaremia caused by D. asiatica filarial worms. Case-patient 1, who had underlying conditions, was probably immunodeficient to some extent, enabling the maturation of D. asiatica larvae into adults, whereas case-patient 2 may have had multiple exposure events.

A literature review revealed use of 3 treatment regimens with no preference of one over the other (11). The first 2 regimens were diethylcarbamazine/albendazole combination therapy or doxycycline/albendazole combination therapy targeting the endosymbiont Wolbachia. The third regimen was ivermectin (200 μg/kg/d for 4 d) and doxycycline (100 mg 2×/d for 7 d) (12). We used the diethylcarbamazine/albendazole and doxycycline/albendazole regimens because ivermectin was not registered for human use in Sri Lanka at the time of treatment. Although both treatment regimens achieved clearance of microfilaremia, the viability of adult worms remains uncertain; attempts to locate adult worms were unsuccessful. Thus, we deliberated recommendations for annual follow-up by blood screening for 5 years.

Our report establishes the presence of accidental D. asiatica infections among humans in Sri Lanka who were asymptomatic with microfilaremia. Further investigations will support the establishment of dirofilariasis as a zoonotic public health problem. We recommend routine administration of antifilarial drugs to dogs and cats, control of mosquitoes, and raising awareness of dirofilariasis.